Veracyte (VCYT) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Veracyte (VCYT) over the last 7 years, with Q3 2025 value amounting to $0.24.
- Veracyte's EPS (Weighted Average and Diluted) rose 2631.58% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.38, marking a year-over-year increase of 37142.86%. This contributed to the annual value of $0.31 for FY2024, which is 13027.6% up from last year.
- As of Q3 2025, Veracyte's EPS (Weighted Average and Diluted) stood at $0.24, which was up 2631.58% from -$0.01 recorded in Q2 2025.
- In the past 5 years, Veracyte's EPS (Weighted Average and Diluted) registered a high of $0.24 during Q3 2025, and its lowest value of -$0.66 during Q1 2021.
- Over the past 5 years, Veracyte's median EPS (Weighted Average and Diluted) value was -$0.12 (recorded in 2022), while the average stood at -$0.11.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 66000.0% in 2023, then skyrocketed by 55000.0% in 2025.
- Veracyte's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.14 in 2021, then skyrocketed by 64.29% to -$0.05 in 2022, then plummeted by 660.0% to -$0.38 in 2023, then skyrocketed by 117.3% to $0.07 in 2024, then skyrocketed by 265.18% to $0.24 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.24 for Q3 2025, versus -$0.01 for Q2 2025 and $0.09 for Q1 2025.